EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc.（EYPT）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · EYPT · 截至 Jun 8, 2026
关键指标
探索 EyePoint Pharmaceuticals, Inc. 数据
eypt stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 18 · 买入占比: 88.9%
根据过去 3 个月内 18 位华尔街分析师，EYPT 共识评级为 Buy，12 个月平均目标价 $37.50 （较现价 $11.78 上涨空间 218.34%）。
竞争对手与同行
eypt competitorsEYPT
BCAX
KOD
KURA
NRIX
PRME股票表现
完整历史关于 EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The com…
what is eyepoint pharmaceuticals, inc. · eypt stock overview · eyepoint pharmaceuticals, inc. company profile · who is eyepoint pharmaceuticals, inc. ceo · eypt NASDAQ · eyepoint pharmaceuticals, inc. headquarters · eyepoint pharmaceuticals, inc. business segments
关于股票概览与关键数据
EyePoint Pharmaceuticals, Inc.（EYPT）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 27, 2005 在 NASDAQ 上市。截至最近交易日，EYPT 股价为 $11.78，市值约为 $987.7M。过去12个月累计回报 +31.91%，年初至今回报 -35.52%。
根据 18 位华尔街分析师，EyePoint Pharmaceuticals, Inc. 股票共识评级为Buy，12个月平均目标价为 $37.50。2025 财年 EyePoint Pharmaceuticals, Inc. 营收 $31.4M，净利润 -$232.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。
常见问题
截至最近一个交易日，EyePoint Pharmaceuticals, Inc.（EYPT）股价为 $11.78，在 NASDAQ 上市，52周区间为 $7.94 – $19.11。